GO:0098664 G protein-coupled serotonin receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098664 describes the molecular signaling cascade triggered when a G protein-coupled serotonin receptor binds its physiological ligand, most prominently serotonin (5-hydroxytryptamine, 5-HT).
• The pathway is initiated by ligand binding to 5-HT receptors such as 5-HT2A, 5-HT1A, and other GPCR family members, which then activate heterotrimeric G proteins (Gq, Gi/o, Gs) and downstream effectors.
• G protein-specific mechanisms at the 5-HT2A receptor regulate psychosis-related effects and memory deficits, highlighting the pathway's role in neuropsychiatric disease.
• The 5-HT1A receptor exhibits Gα protein signaling bias, meaning different ligands can preferentially activate distinct G protein subtypes, which has therapeutic implications.
• Ligand-free (constitutive) signaling of serotonin GPCRs contributes to basal physiology and pharmacology, and is modulated by receptor expression levels and genetic variants.
• The pathway is a validated drug target for schizophrenia, nausea/vomiting, and hallucinogen-induced perceptual changes, making it a focus for CRISPR-based disease modeling.
Description
The G protein-coupled serotonin receptor signaling pathway (GO:0098664) is a biological process defined as the series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands. Serotonin (5-HT) is a monoamine neurotransmitter that exerts its effects through a family of GPCRs, and this pathway represents the canonical mechanism by which serotonin modulates neuronal excitability, mood, perception, and numerous peripheral functions. The pathway is initiated at the plasma membrane and propagates through heterotrimeric G proteins to second messengers and downstream kinases, ultimately influencing gene expression and cellular behavior. Researchers study GO:0098664 because it is central to neuropsychopharmacology and drug discovery. Hallucinogens such as LSD and psilocybin act primarily through 5-HT2A receptor-mediated signaling, and the G protein-specific mechanisms of this receptor have been linked to psychosis-related effects and memory deficits. The 5-HT1A receptor, another key member, displays biased signaling toward different Gα subunits, which complicates but also enriches therapeutic targeting. Moreover, ligand-free signaling of these receptors contributes to basal activity, and genetic variations can alter pathway output, making it relevant to personalized medicine. Dysregulation of this pathway is implicated in schizophrenia, nausea and vomiting, and other conditions. Understanding the precise molecular steps, the genes involved, and the experimental models available is essential for developing targeted therapies. This article provides a research-grade overview of GO:0098664, integrating authoritative QuickGO annotation with real PubMed literature, and outlines how CRISPR-based models can be used to dissect its components.
G protein-coupled serotonin receptor signaling pathway At A Glance
| GO ID | GO:0098664 |
|---|---|
| GO term | G protein-coupled serotonin receptor signaling pathway |
| Ontology | biological_process |
| Synonym | G-protein coupled serotonin receptor signaling pathway |
| Definition | The series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands. |
| Major function | Transduces extracellular serotonin signals into intracellular responses via heterotrimeric G proteins and second messengers. |
| Key receptors | 5-HT2A, 5-HT1A, and other serotonin GPCRs. |
| G protein subtypes | Gq, Gi/o, Gs, and others, depending on receptor and ligand. |
| Associated diseases | Schizophrenia, psychosis, nausea/vomiting, and hallucinogen-induced states. |
What Is GO:0098664?
GO:0098664, G protein-coupled serotonin receptor signaling pathway, is defined by QuickGO as the series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands. In simpler terms, it is the entire communication cascade that begins when serotonin (or a related ligand) docks onto a specific class of serotonin receptors on the cell surface, and ends with changes inside the cell such as altered enzyme activity, ion channel function, or gene transcription. This process is a biological_process in the Gene Ontology and is synonymous with G-protein coupled serotonin receptor signaling pathway.
Why Is G protein-coupled serotonin receptor signaling pathway Important in Cell Biology?
GO:0098664 is critically important because it governs how serotonin, a master regulator of mood, cognition, and gastrointestinal function, communicates with cells. The pathway is the primary target of many psychiatric medications, including atypical antipsychotics and antiemetics, and is the mechanism through which hallucinogens exert their profound effects on perception. Understanding the precise G protein-specific mechanisms at receptors like 5-HT2A and 5-HT1A can reveal why some drugs cause psychosis-like effects while others are therapeutic, and can guide the development of biased ligands with fewer side effects. Furthermore, constitutive (ligand-free) activity of these receptors adds another layer of regulation that is relevant to disease and drug response.
• Mediates the actions of serotonin, a neurotransmitter involved in mood, sleep, appetite, and cognition.
• Central to the mechanism of action of hallucinogens such as LSD and psilocybin, which activate 5-HT2A receptor signaling.
• Implicated in schizophrenia pathophysiology and is a target for antipsychotic drug development.
• Regulates nausea and vomiting through serotonin GPCR signaling in the gut and brainstem.
• Exhibits G protein signaling bias, allowing ligands to selectively activate different downstream pathways.
• Constitutive, ligand-free signaling contributes to basal cellular activity and can be altered by receptor mutations.
• Provides a model system for studying GPCR pharmacology and signal transduction.
• Offers opportunities for CRISPR-based disease modeling and drug screening.
What Happens During G protein-coupled serotonin receptor signaling pathway?
Ligand binding and receptor activation
In simple terms: Serotonin binds to its receptor on the cell surface, like a key fitting a lock, and switches the receptor on.
The pathway begins when a physiological ligand, typically serotonin (5-HT), binds to the orthosteric site of a G protein-coupled serotonin receptor such as 5-HT2A or 5-HT1A. This binding induces a conformational change in the receptor, enabling it to act as a guanine nucleotide exchange factor for heterotrimeric G proteins. Different ligands can stabilize distinct receptor conformations, leading to biased signaling toward specific G protein subtypes.
G protein activation and effector modulation
In simple terms: The activated receptor turns on a G protein, which then switches on or off other proteins inside the cell.
Upon activation, the receptor catalyzes the exchange of GDP for GTP on the Gα subunit of the heterotrimeric G protein. For 5-HT2A, this is primarily Gq, which activates phospholipase C to produce inositol trisphosphate and diacylglycerol, mobilizing calcium and activating protein kinase C. For 5-HT1A, coupling to Gi/o inhibits adenylyl cyclase and reduces cAMP, while also modulating ion channels. The specificity of G protein coupling is a key determinant of downstream effects.
Second messenger generation and downstream signaling
In simple terms: The G protein triggers a chain reaction of small molecules that amplify the signal and change cell behavior.
Activated G proteins regulate effector enzymes such as adenylyl cyclase and phospholipase C, generating second messengers like cAMP, IP3, and DAG. These second messengers activate kinases including PKA and PKC, which phosphorylate target proteins and alter neuronal excitability, gene expression, and synaptic plasticity. The pathway also intersects with other signaling cascades, such as those involving tissue transglutaminase, which can modify GPCR function.
Receptor desensitization and regulatory feedback
In simple terms: After signaling, the receptor is turned off or internalized to prevent overstimulation.
Prolonged activation leads to receptor phosphorylation by G protein-coupled receptor kinases, followed by arrestin recruitment and internalization, which terminates signaling and can initiate new signaling waves. This desensitization is crucial for maintaining homeostasis and is a target for drug development. Additionally, ligand-free (constitutive) receptor activity can contribute to basal signaling, and its regulation is influenced by receptor expression levels and genetic variants.
Key Genes Involved in GO:0098664 G protein-coupled serotonin receptor signaling pathway
The following genes encode the receptors, G proteins, and downstream effectors that constitute the G protein-coupled serotonin receptor signaling pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HTR2A | Encodes the 5-HT2A receptor, a Gq-coupled GPCR | Primary target of hallucinogens; linked to psychosis and memory |
| HTR1A | Encodes the 5-HT1A receptor, a Gi/o-coupled GPCR | Shows Gα signaling bias; target for anxiolytics and antidepressants |
| HTR2C | Encodes the 5-HT2C receptor, a Gq-coupled GPCR | Regulates appetite and mood; implicated in obesity and depression |
| HTR4 | Encodes the 5-HT4 receptor, a Gs-coupled GPCR | Modulates gastrointestinal motility and memory |
| HTR7 | Encodes the 5-HT7 receptor, a Gs-coupled GPCR | Involved in circadian rhythm and thermoregulation |
| GNAQ | Encodes Gαq subunit | Mediates 5-HT2A signaling to phospholipase C |
| GNAI1 | Encodes Gαi1 subunit | Mediates 5-HT1A signaling to inhibit adenylyl cyclase |
| GNAS | Encodes Gαs subunit | Mediates 5-HT4/7 signaling to activate adenylyl cyclase |
| PLCB1 | Encodes phospholipase C beta 1 | Effector for Gq-coupled serotonin receptors |
| ADCY1 | Encodes adenylyl cyclase 1 | Effector for Gs-coupled serotonin receptors |
| PRKCA | Encodes protein kinase C alpha | Downstream kinase in 5-HT2A signaling |
| ARRB1 | Encodes beta-arrestin 1 | Regulates receptor desensitization and internalization |
| TGM2 | Encodes tissue transglutaminase | Modifies GPCR function and signaling |
| SLC6A4 | Encodes serotonin transporter | Regulates extracellular serotonin levels, indirectly affecting pathway |
| TPH1 | Encodes tryptophan hydroxylase 1 | Rate-limiting enzyme for serotonin synthesis in periphery |
| TPH2 | Encodes tryptophan hydroxylase 2 | Rate-limiting enzyme for serotonin synthesis in brain |
| DDC | Encodes dopa decarboxylase | Catalyzes serotonin synthesis from 5-HTP |
How Is G protein-coupled serotonin receptor signaling pathway Regulated?
The G protein-coupled serotonin receptor signaling pathway is tightly regulated at multiple levels. Receptor desensitization and internalization are controlled by G protein-coupled receptor kinases and arrestins, which terminate signaling and can initiate alternative signaling cascades. Ligand-free (constitutive) activity of these receptors contributes to basal signaling and is modulated by receptor expression levels and genetic variants. Additionally, tissue transglutaminase can post-translationally modify GPCRs, affecting their function and signaling. Downstream, second messenger levels are balanced by phosphodiesterases and phosphatases, ensuring transient and specific responses.
G protein-coupled serotonin receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HTR2A | Schizophrenia, psychosis, memory deficits | Knockout or point-mutation in neuronal cell lines; behavioral assays in mice |
| HTR1A | Anxiety, depression, biased signaling | Knock-in of biased variants; cAMP assays |
| HTR4 | Nausea, gastrointestinal motility disorders | Overexpression in enterochromaffin cells; motility assays |
| TGM2 | Neurodegeneration, GPCR modification | Knockout in neuronal cells; protein interaction studies |
| SLC6A4 | Depression, serotonin reuptake | Knockout or overexpression; serotonin uptake assays |
Schizophrenia and psychosis
Alterations in serotonin GPCR signaling, particularly at the 5-HT2A receptor, have been implicated in schizophrenia and psychosis. G protein-specific mechanisms at 5-HT2A regulate psychosis-related effects and memory deficits, and many atypical antipsychotics target this receptor. The pathway's modulation by hallucinogens further supports its role in perceptual disturbances.
Nausea and vomiting
Serotonin GPCR signaling in the gut and brainstem is a key driver of nausea and vomiting. 5-HT4 receptor activation and 5-HT3 receptor (a ligand-gated ion channel, not GPCR) signaling are involved, but GPCR-mediated pathways also contribute to emetic responses. Antiemetic drugs often target these serotonin receptors.
Neurodegeneration and memory
The 5-HT2A receptor and its G protein-specific signaling have been linked to memory deficits, suggesting a role in cognitive disorders. Additionally, tissue transglutaminase, which can modify GPCRs, is implicated in neurodegenerative diseases such as Huntington's and Alzheimer's, potentially affecting serotonin signaling.
From G protein-coupled serotonin receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HTR2A abolish hallucinogen-induced signaling? | HTR2A knockout cell line (e.g., HEK293) |
| Does a specific point mutation in HTR1A alter G protein bias? | Point-mutation knock-in via CRISPR |
| Can a tagged 5-HT2A receptor be used to track internalization? | Tagged knock-in (e.g., GFP) |
| Does overexpression of GNAQ enhance downstream signaling? | Overexpression cell line |
| What is the role of TGM2 in modulating GPCR function? | TGM2 knockout or overexpression |
| Can CRISPR library screening identify novel regulators of serotonin signaling? | Genome-wide CRISPR knockout library in reporter cells |
How to Study the G protein-coupled serotonin receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Loss-of-function effects on signaling | Identify novel regulators of serotonin GPCR pathway |
| cAMP assay | Gi/o or Gs activity | Assess 5-HT1A or 5-HT4 signaling |
| Calcium flux assay | Gq activity | Measure 5-HT2A activation |
| Beta-arrestin recruitment | Receptor desensitization | Study biased signaling |
| Immunoblotting | Protein expression and phosphorylation | Validate downstream kinase activation |
| Immunofluorescence | Receptor localization | Track internalization |
| RNA-seq | Transcriptional changes | Identify gene expression changes downstream of pathway |
| Behavioral assays | Psychosis-like or memory behaviors | Evaluate in vivo effects of mutations |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate G protein-coupled serotonin receptor signaling. For example, yeast-based biosensors have been engineered to detect serotonin GPCR activation and can be coupled with CRISPR libraries to uncover modulators.
Second messenger assays
Measurements of cAMP, IP3, or calcium flux are standard for assessing serotonin GPCR signaling. These assays can be used to evaluate G protein bias and the effects of mutations.
Receptor internalization and trafficking
Tagged receptors (e.g., GFP or luciferase) allow real-time imaging of internalization and desensitization. This is critical for understanding regulatory mechanisms.
Behavioral and physiological models
Animal models with genetic modifications in serotonin receptors or G proteins can be used to study psychosis-related behaviors, memory, and emesis.
How CRISPR Can Be Used to Study GO:0098664 G protein-coupled serotonin receptor signaling pathway
Knockout
CRISPR knockout of serotonin receptor genes (e.g., HTR2A, HTR1A) or G protein subunits (e.g., GNAQ) can abolish specific signaling branches, allowing researchers to dissect pathway components. For example, HTR2A knockout cells are used to confirm the receptor's role in hallucinogen responses.
Point Mutation
Introducing precise point mutations via CRISPR can mimic naturally occurring variants or create biased receptors. For instance, mutations in HTR1A can alter G protein coupling, helping to map signaling bias.
Knock-in
Knock-in of tagged receptors (e.g., GFP-HTR2A) enables real-time tracking of receptor trafficking and signaling in live cells. This approach is valuable for studying desensitization and internalization.
Overexpression
Overexpression of wild-type or mutant receptors and G proteins can amplify signaling for biochemical assays. This is useful for studying constitutive activity and ligand-free signaling.
How EDITGENE Supports G protein-coupled serotonin receptor signaling pathway Research
Researchers studying G protein-coupled serotonin receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling functional validation of genes such as HTR2A, HTR1A, and GNAQ in the context of GO:0098664.
Contact EDITGENE today to design your custom CRISPR model for G protein-coupled serotonin receptor signaling pathway research.
Frequently Asked Questions About G protein-coupled serotonin receptor signaling pathway
What is GO:0098664?
GO:0098664 is the Gene Ontology term for the G protein-coupled serotonin receptor signaling pathway, defined as the series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands.
What genes are involved in G protein-coupled serotonin receptor signaling pathway?
Key genes include HTR2A, HTR1A, HTR2C, HTR4, HTR7, GNAQ, GNAI1, GNAS, PLCB1, and ADCY1, among others.
What is the function of the G protein-coupled serotonin receptor signaling pathway?
It transduces extracellular serotonin signals into intracellular responses, regulating mood, perception, cognition, and gastrointestinal function.
How is the G protein-coupled serotonin receptor signaling pathway regulated?
It is regulated by receptor desensitization, internalization via arrestins, constitutive activity, and post-translational modifications such as those by tissue transglutaminase.
What diseases are associated with G protein-coupled serotonin receptor signaling pathway?
Schizophrenia, psychosis, memory deficits, nausea and vomiting, and neurodegenerative conditions have been linked to this pathway.
What is G protein signaling bias at serotonin receptors?
It is the ability of different ligands to preferentially activate distinct G protein subtypes, as seen at the 5-HT1A receptor, which can lead to different downstream effects.
How can CRISPR be used to study G protein-coupled serotonin receptor signaling pathway?
CRISPR can create knockouts, point mutations, knock-ins, and overexpression models of serotonin receptors and G proteins to dissect their roles in the pathway.
What are the main receptors in G protein-coupled serotonin receptor signaling pathway?
The main receptors are 5-HT2A, 5-HT1A, 5-HT2C, 5-HT4, and 5-HT7, all of which are GPCRs.
What is ligand-free signaling in serotonin GPCRs?
It is constitutive receptor activity in the absence of ligand, which contributes to basal signaling and can be influenced by genetic variants.
How does tissue transglutaminase affect serotonin receptor signaling?
Tissue transglutaminase can modify GPCRs post-translationally, affecting their function and downstream signaling.
Conclusion
GO:0098664, the G protein-coupled serotonin receptor signaling pathway, is a fundamental biological process that mediates the diverse actions of serotonin. Its components, from receptors like 5-HT2A and 5-HT1A to G proteins and downstream effectors, are implicated in major neuropsychiatric and gastrointestinal disorders. Understanding the pathway's regulation, including biased signaling and constitutive activity, is essential for rational drug design. CRISPR-based models offer powerful tools to dissect this pathway with unprecedented precision. By creating knockout, point-mutation, knock-in, and overexpression cell lines, researchers can validate gene function and identify new therapeutic targets. EDITGENE's services support these efforts, providing custom CRISPR solutions and bioinformatics to accelerate discoveries in serotonin signaling research.
References
- 1. López-Giménez JF et al.. 2018. Hallucinogens and Serotonin 5-HT(2A) Receptor-Mediated Signaling Pathways.. Curr Top Behav Neurosci 36:45-73 PMID: 28677096
- 2. Stępnicki P et al.. 2018. Current Concepts and Treatments of Schizophrenia.. Molecules 23(8) PMID: 30127324
- 3. Yao Z et al.. 2024. Tissue transglutaminase: a multifunctional and multisite regulator in health and disease.. Physiol Rev 104(1):281-325 PMID: 37712623
- 4. Kossatz E et al.. 2024. G protein-specific mechanisms in the serotonin 5-HT(2A) receptor regulate psychosis-related effects and memory deficits.. Nat Commun 15(1):4307 PMID: 38811567
- 5. Lengger B et al.. 2022. Serotonin G Protein-Coupled Receptor-Based Biosensing Modalities in Yeast.. ACS Sens 7(5):1323-1335 PMID: 35452231
- 6. Alabdali R et al.. 2023. Gα Protein Signaling Bias at Serotonin 1A Receptor.. Mol Pharmacol 104(5):230-238 PMID: 37567783
- 7. Sadee W. 2023. Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics.. Molecules 28(17) PMID: 37687205
- 8. Zhong W et al.. 2021. Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.. Int J Mol Sci 22(11) PMID: 34071460
